ZFIN ID: ZDB-FISH-161027-1
Fish name: s705Tg ; as3Tg
Genotype: s705Tg ; as3Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by s705Tg ; as3Tg
No data available
GENE EXPRESSION
Gene expression in s705Tg ; as3Tg
RNA expression No data available
Protein expression No data available
Reporter gene expression
Expressed Gene Structure Conditions Figures
EGFP standard conditions Fig. 1Fig. 5 from Cox et al., 2016
PHENOTYPE
Phenotype in s705Tg ; as3Tg
Phenotype Conditions Figures
liver hyperplastic, abnormal standard conditions Fig. 1 from Cox et al., 2016
liver increased mass, abnormal standard conditions Fig. 1 from Cox et al., 2016
liver increased size, abnormal standard conditions Fig. 1Fig. 5Fig. 6 from Cox et al., 2016
liver increased volume, abnormal standard conditions Fig. 1 from Cox et al., 2016
liver neoplastic, abnormal standard conditions Fig. 1 from Cox et al., 2016
liver size, ameliorated chemical treatment: methionine sulfoximine Fig. 5Fig. 6 from Cox et al., 2016
liver size, ameliorated chemical treatment: sirolimus Fig. 6 from Cox et al., 2016
liver size, ameliorated chemical treatment: methionine sulfoximine, chemical treatment: sirolimus Fig. 6 from Cox et al., 2016
liver size, ameliorated chemical treatment: 5-fluorouracil Fig. 5 from Cox et al., 2016
liver size, ameliorated chemical treatment: methionine sulfoximine, chemical treatment: 5-fluorouracil Fig. 5 from Cox et al., 2016
liver size, ameliorated chemical treatment: mycophenolic acid Fig. 5 from Cox et al., 2016
liver size, ameliorated chemical treatment: mycophenolic acid, chemical treatment: methionine sulfoximine Fig. 5 from Cox et al., 2016
liver cholangiocarcinoma increased occurrence, abnormal standard conditions Fig. 1 from Cox et al., 2016
liver hepatocellular carcinoma increased occurrence, abnormal standard conditions Fig. 1 from Cox et al., 2016

CITATIONS  (1)